When PT-141 finally hit the prescription market, it was released as Vyleesi, an injectable intended not for men with ED but for premenopausal women whove lost their sexual desire (i.e., hypoactive sexual desire disorder).4 12 As of this writing, the United States Food & Drug Administration (FDA) has not approved PT-141 for the treatment of ED, although it can be obtained as an off-label ED treatment injectable or intranasal through certain prescription channels
Similarly, preclinical research involving animals must comply with Institutional Animal Care and Use Committee (IACUC) directives and adhere to Animal Welfare Act (AWA) standards
Our comprehensive pre-treatment evaluation includes a thorough medical history review, physical examination, advanced metabolic and hormonal testing, and screening for contraindications and potential drug interactions
These findings show that GLP-1s may hold promise as an adjunct therapy to insulin to reduce cardiovascular and kidney disease among individuals with T1D
This matters more than it might seem
Pregnenolone, dehydroepiandrosterone, and schizophrenia: alterations and clinical trials
